UNIVERSITY OF UTAH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-02-28
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.utah.edu
Optimize Low Back Pain
Phase 3
Active, not recruiting
- Conditions
- Low Back PainChronic Pain
- Interventions
- Behavioral: Physical TherapyBehavioral: Cognitive Behavioral TherapyBehavioral: Mindfulness
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 748
- Registration Number
- NCT03859713
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸Intermountain Health Care, Salt Lake City, Utah, United States
🇺🇸The University of Utah Healthcare System, Salt Lake City, Utah, United States
Translational Control of Anabolic Resistance in Aging Muscle
Not Applicable
Completed
- Conditions
- Physical Inactivity
- Interventions
- Other: Reduced Physical Activity
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 9
- Registration Number
- NCT03839628
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Optimizing Pregnancy and Treatment Interventions for Moms 2.0
Not Applicable
Completed
- Conditions
- Pregnancy RelatedOpioid-Related DisordersPregnancy, High Risk
- Interventions
- Behavioral: Patient Navigation
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 106
- Registration Number
- NCT03833245
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸Magee Women's Hospital, Pittsburgh, Pennsylvania, United States
Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer
Phase 2
Terminated
- Conditions
- Castration-Sensitive Prostate CarcinomaStage IVB Prostate CancerStage IVA Prostate CancerStage IV Prostate CancerMetastatic Prostatic Adenocarcinoma
- Interventions
- Drug: Antiandrogen TherapyDrug: Abiraterone AcetateDrug: DocetaxelOther: Quality-of-Life AssessmentDrug: PrednisoneOther: Questionnaire Administration
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 1
- Registration Number
- NCT03827473
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Evaluation of a Dashboard for Diabetes Care Integrated With the Electronic Health Record
Not Applicable
Completed
- Conditions
- Diabetes MellitusDiabetes Mellitus, Type 2
- Interventions
- Other: EHR-integrated diabetes dashboard
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 13155
- Registration Number
- NCT03826290
- Locations
- 🇺🇸
University of Utah Health, Salt Lake City, Utah, United States
Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Stage IV Pancreatic CancerMetastatic Pancreatic CarcinomaStage II Pancreatic CancerUnresectable Pancreatic CarcinomaStage IIB Pancreatic CancerStage III Pancreatic CancerStage IIA Pancreatic Cancer
- Interventions
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 39
- Registration Number
- NCT03825289
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
Combining Flash Glucose Monitoring and Online Peer Support to Improve Outcomes in Hispanics With Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: Flash Glucose Monitoring with Online Peer Support
- First Posted Date
- 2019-01-10
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 34
- Registration Number
- NCT03799796
- Locations
- 🇺🇸
University of Utah College of Nursing, Salt Lake City, Utah, United States
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer
Phase 2
Active, not recruiting
- Conditions
- Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate AdenocarcinomaPSA FailureOligometastasisMetastatic Malignant Neoplasm in the Lymph Nodes
- Interventions
- Radiation: Hypofractionated Radiation TherapyProcedure: MetastasectomyOther: Quality-of-Life AssessmentRadiation: Intensity-Modulated Radiation TherapyOther: Questionnaire AdministrationRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 20
- Registration Number
- NCT03796767
- Locations
- 🇺🇸
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: Cost Discussion
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 100
- Registration Number
- NCT03780491
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels
Terminated
- Conditions
- Iron Overload
- Interventions
- Diagnostic Test: Serum Ferritin levelDiagnostic Test: Serum Ferritin iron contentDiagnostic Test: Urine Ferritin levelDiagnostic Test: Urine ferritin iron content
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 11
- Registration Number
- NCT03777904
- Locations
- 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States
© Copyright 2025. All Rights Reserved by MedPath